Your browser doesn't support javascript.
loading
Prevalence and phenotype of the c.1529C>T SPG7 variant in adult-onset cerebellar ataxia in Italy.
Mancini, C; Giorgio, E; Rubegni, A; Pradotto, L; Bagnoli, S; Rubino, E; Prontera, P; Cavalieri, S; Di Gregorio, E; Ferrero, M; Pozzi, E; Riberi, E; Ferrero, P; Nigro, P; Mauro, A; Zibetti, M; Tessa, A; Barghigiani, M; Antenora, A; Sirchia, F; Piacentini, S; Silvestri, G; De Michele, G; Filla, A; Orsi, L; Santorelli, F M; Brusco, A.
Affiliation
  • Mancini C; Department of Medical Sciences, University of Torino, Turin, Italy.
  • Giorgio E; Department of Medical Sciences, University of Torino, Turin, Italy.
  • Rubegni A; Molecular Medicine, IRCCS Fondazione Stella Maris, Pisa, Italy.
  • Pradotto L; Division of Neurology and Neurorehabilitation, San Giuseppe Hospital, IRCCS Istituto Auxologico Italiano, Piancavallo, Italy.
  • Bagnoli S; Department of Neuroscience, Psychology, Drug Research and Child's Health, University of Florence, Florence, Italy.
  • Rubino E; Department of Neuroscience and Mental Health, Città della Salute e della Scienza University Hospital, Turin, Italy.
  • Prontera P; Medical Genetics Unit, Hospital S. Maria della Misericordia, Perugia, Italy.
  • Cavalieri S; Department of Medical Sciences, University of Torino, Turin, Italy.
  • Di Gregorio E; Department of Medical Sciences, University of Torino, Turin, Italy.
  • Ferrero M; Department of Medical Sciences, University of Torino, Turin, Italy.
  • Pozzi E; Department of Medical Sciences, University of Torino, Turin, Italy.
  • Riberi E; Department of Medical Sciences, University of Torino, Turin, Italy.
  • Ferrero P; Department of Neuroscience and Mental Health, Città della Salute e della Scienza University Hospital, Turin, Italy.
  • Nigro P; Clinica Neurologica, Azienda Ospedaliera - Università di Perugia, Perugia, Italy.
  • Mauro A; Department of Neurosciences, University of Torino, Turin, Italy.
  • Zibetti M; Department of Neuroscience and Mental Health, Città della Salute e della Scienza University Hospital, Turin, Italy.
  • Tessa A; Molecular Medicine, IRCCS Fondazione Stella Maris, Pisa, Italy.
  • Barghigiani M; Molecular Medicine, IRCCS Fondazione Stella Maris, Pisa, Italy.
  • Antenora A; Department of Neurosciences, Federico II University, Naples, Italy.
  • Sirchia F; Institute for Maternal and Child Health - IRCCS Burlo Garofolo, Trieste, Italy.
  • Piacentini S; Department of Neuroscience, Psychology, Drug Research and Child's Health, University of Florence, Florence, Italy.
  • Silvestri G; Fondazione Policlinico Universitario IRCCS, A. Gemelli, Rome, Italy.
  • De Michele G; Università Cattolica del Sacro Cuore, Rome, Italy.
  • Filla A; Department of Neurosciences, Federico II University, Naples, Italy.
  • Orsi L; Department of Neurosciences, Federico II University, Naples, Italy.
  • Santorelli FM; Department of Neuroscience and Mental Health, Città della Salute e della Scienza University Hospital, Turin, Italy.
  • Brusco A; Molecular Medicine, IRCCS Fondazione Stella Maris, Pisa, Italy.
Eur J Neurol ; 26(1): 80-86, 2019 01.
Article de En | MEDLINE | ID: mdl-30098094
ABSTRACT
BACKGROUND AND

PURPOSE:

Hereditary ataxias are heterogeneous groups of neurodegenerative disorders, characterized by cerebellar syndromes associated with dysarthria, oculomotor and corticospinal signs, neuropathy and cognitive impairment. Recent reports have suggested mutations in the SPG7 gene, causing the most common form of autosomal recessive spastic paraplegia (MIM#607259), as a main cause of ataxias. The majority of described patients were homozygotes or compound heterozygotes for the c.1529C>T (p.Ala510Val) change. We screened a cohort of 895 Italian patients with ataxia for p.Ala510Val in order to define the prevalence and genotype-phenotype correlation of this variant.

METHODS:

We set up a rapid assay for c.1529C>T using restriction enzyme analysis after polymerase chain reaction amplification. We confirmed the diagnosis with Sanger sequencing.

RESULTS:

We identified eight homozygotes and 13 compound heterozygotes, including two novel variants affecting splicing. Mutated patients showed a pure cerebellar ataxia at onset, evolving in mild spastic ataxia (alternatively) associated with dysarthria (~80% of patients), urinary urgency (~30%) and pyramidal signs (~70%). Comparing homozygotes and compound heterozygotes, we noted a difference in age at onset and Scale for the Assessment and Rating of Ataxia score between the two groups, supporting an earlier and more severe phenotype in compound heterozygotes versus homozygotes.

CONCLUSIONS:

The SPG7 c.1529C>T (p.Ala510Val) mutants accounted for 2.3% of cerebellar ataxia cases in Italy, suggesting that this variant should be considered as a priority test in the presence of late-onset pure ataxia. Moreover, the heterozygous/homozygous genotype appeared to predict the onset of clinical manifestation and disease progression.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Metalloendopeptidases / Ataxie cérébelleuse / ATPases associated with diverse cellular activities Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Aged80 / Female / Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Eur J Neurol Sujet du journal: NEUROLOGIA Année: 2019 Type de document: Article Pays d'affiliation: Italie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Metalloendopeptidases / Ataxie cérébelleuse / ATPases associated with diverse cellular activities Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Aged80 / Female / Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Eur J Neurol Sujet du journal: NEUROLOGIA Année: 2019 Type de document: Article Pays d'affiliation: Italie